{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:52:16Z","timestamp":1788223936366,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["A-12-323-22&23&24"],"award-info":[{"award-number":["A-12-323-22&23&24"]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ibneur.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T13:14:09Z","timestamp":1736514849000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats"],"prefix":"10.1016","volume":"18","author":[{"given":"Mahdieh","family":"Anoush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Taghaddosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Bokaei Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Bijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Kalantari-Hesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir-Jamal","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ibneur.2025.01.008_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.21608\/jmh.2020.40221.1081","article-title":"Dark neurons: a protective mechanism or a mode of death","volume":"3","author":"Ahmadpour","year":"2019","journal-title":"J. Med. Histol."},{"key":"10.1016\/j.ibneur.2025.01.008_bib2","first-page":"73","article-title":"Biochemical interaction analysis of natural SGLT2 inhibitors with Alzheimer targets: a computational approach","volume":"11","author":"Alafnan","year":"2020","journal-title":"J. Biochem Technol."},{"key":"10.1016\/j.ibneur.2025.01.008_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107729","article-title":"Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats","volume":"96","author":"Ali","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.008_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271138","article-title":"Effects of antidiabetic agents on Alzheimer\u2019s disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin","volume":"17","author":"Ali","year":"2022","journal-title":"Plos One"},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1515\/labmed-2019-0098","article-title":"A colorimetric method to measure oxidized, reduced and total glutathione levels in erythrocytes","volume":"43","author":"Alisik","year":"2019","journal-title":"J. Lab. Med."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/fcp.12548","article-title":"Empagliflozin attenuates transient cerebral ischemia\/reperfusion injury in hyperglycemic rats via repressing oxidative\u2013inflammatory\u2013apoptotic pathway","volume":"34","author":"Amin","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ibneur.2025.01.008_bib7","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s11064-019-02761-0","article-title":"Coenzyme Q 10 alleviated behavioral dysfunction and bioenergetic function in an animal model of depression","volume":"44","author":"Andalib","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ibneur.2025.01.008_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9652513","article-title":"Edaravone improves streptozotocin-induced memory impairment via alleviation of behavioral dysfunction, oxidative stress, inflammation, and histopathological parameters","volume":"2023","author":"Anoush","year":"2023","journal-title":"Behav. Neurol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.008_bib9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.55782\/ane-2022-036","article-title":"Thymus daenensis extract prevents scopolamine\u2011induced memory impairment through declining oxidative stress in rats","volume":"82","author":"Anoush","year":"2022","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ibneur.2025.01.008_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.55782\/ane-2022-036","article-title":"Thymus daenensis extract prevents scopolamine\u2011induced memory impairment through declining oxidative stress in rats","volume":"82","author":"Anoush","year":"2022","journal-title":"Acta Neurobiol. Exp."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.008_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4239\/wjd.v5.i6.889","article-title":"Type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"5","author":"Barbagallo","year":"2014","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.008_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.008_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.34172\/apb.2020.052","article-title":"Grape seed oil as a natural therapy in male rats with alzheimer\u2019s diseases","volume":"10","author":"Berahmand","year":"2020","journal-title":"Adv. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.008_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s11064-021-03473-0","article-title":"Neuroprotective effect of apigenin on depressive-like behavior: mechanistic approach","volume":"47","author":"Bijani","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ibneur.2025.01.008_bib15","article-title":"Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ibneur.2025.01.008_bib16","first-page":"S99","article-title":"Human studies related to protein oxidation: protein carbonyl content as a marker of damage","volume":"33","author":"Chevion","year":"2000","journal-title":"Free Radic. Res."},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.008_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/1440-1681.12277","article-title":"Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease","volume":"41","author":"Edwards","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ibneur.2025.01.008_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exger.2015.03.002","article-title":"Migration of blood cells to \u03b2-amyloid plaques in Alzheimer's disease","volume":"65","author":"Hohsfield","year":"2015","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.008_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09295","article-title":"Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats","volume":"8","author":"Hosseini","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ibneur.2025.01.008_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4825472","article-title":"Mitigated oxidative stress and cognitive impairments in transient global ischemia using niosomal selegiline-NBP delivery","volume":"2022","author":"Jafari","year":"2022","journal-title":"Behav. Neurol."},{"issue":"9","key":"10.1016\/j.ibneur.2025.01.008_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/antiox10091439","article-title":"Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer\u2019s disease: the role of antioxidants in prevention and treatment","volume":"10","author":"Juszczyk","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.008_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01322333","article-title":"Lipid peroxidation and activity of antioxidant enzymes in diabetic rats","volume":"151","author":"Kakkar","year":"1995","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.ibneur.2025.01.008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120543","article-title":"Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: a mechanism review","author":"Lingli","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ibneur.2025.01.008_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1021131","article-title":"Perivascular spaces as a potential biomarker of Alzheimer\u2019s disease","volume":"16","author":"Lynch","year":"2022","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib26","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer\u2019s disease as type 3 diabetes: common pathophysiological mechanisms between alzheimer\u2019s disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ibneur.2025.01.008_bib27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00210-015-1134-1","article-title":"A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans","volume":"388","author":"Michel","year":"2015","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2337\/dc21-2434","article-title":"Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction","volume":"45","author":"Mone","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ibneur.2025.01.008_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6623141","article-title":"Edaravone improved behavioral abnormalities, alleviated oxidative stress inflammation, and metabolic homeostasis pathways in depression","volume":"2023","author":"Montazeri","year":"2023","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.ibneur.2025.01.008_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110002","article-title":"Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: targeting the GRP78\/PERK\/eIF2\u03b1\/CHOP pathway and miR-211-5p","author":"Motawi","year":"2022","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.ibneur.2025.01.008_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/DDDT.S50773","article-title":"Update on developments with SGLT2 inhibitors in the management of type 2 diabetes","volume":"8","author":"Nauck","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.008_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/biof.5520340208","article-title":"Lipid peroxidation products as oxidative stress biomarkers","volume":"34","author":"Niki","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.ibneur.2025.01.008_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.659402","article-title":"Neuroprotective roles of the reverse transsulfuration pathway in Alzheimer\u2019s disease","volume":"13","author":"Paul","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"23","key":"10.1016\/j.ibneur.2025.01.008_bib34","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ibneur.2025.01.008_bib35","first-page":"3999","article-title":"Mechanism involved in insulin resistance via accumulation of \u03b2-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer\u2019s disease","author":"Rad","year":"2018","journal-title":"Drug Des., Dev. Ther."},{"issue":"18","key":"10.1016\/j.ibneur.2025.01.008_bib36","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1002\/slct.202100773","article-title":"Glutathione: role in oxidative\/nitrosative stress, antioxidant defense, and treatments","volume":"6","author":"Raj Rai","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ibneur.2025.01.008_bib37","article-title":"Oxidative damage to proteins: Spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994"},{"key":"10.1016\/j.ibneur.2025.01.008_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106062","article-title":"Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment","author":"Rizzo","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.008_bib39","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/s41598-020-64349-x","article-title":"Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles","volume":"10","author":"Rom","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.008_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ab.2012.01.030","article-title":"Assessment of reduced glutathione: comparison of an optimized fluorometric assay with enzymatic recycling method","volume":"423","author":"Rou\u0161ar","year":"2012","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.ibneur.2025.01.008_bib41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4239\/wjd.v6.i12.1223","article-title":"Molecular and biochemical trajectories from diabetes to Alzheimer\u2019s disease: a critical appraisal","volume":"6","author":"Sandhir","year":"2015","journal-title":"World J. Diabetes"},{"issue":"17","key":"10.1016\/j.ibneur.2025.01.008_bib42","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.3390\/ijerph20176671","article-title":"Immunomodulatory effects of SGLT2 inhibitors\u2014targeting inflammation and oxidative stress in aging","volume":"20","author":"Sch\u00f6nberger","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.008_bib43","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib44","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1134\/S0022093022050234","article-title":"An Experimental Study of the Neuroprotective Effect of Sodium\u2013GlucoseCotransporter Type 2 Inhibitors","volume":"58","author":"Simanenkova","year":"2022","journal-title":"J. Evol. Biochem. Physiol"},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1021\/acschemneuro.8b00011","article-title":"Scopolamine-induced memory impairment is alleviated by xanthotoxin: role of acetylcholinesterase and oxidative stress processes","volume":"9","author":"Skalicka-Wozniak","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/biomedicines9050576","article-title":"Systemic actions of SGLT2 inhibition on chronic mTOR activation as a shared pathogenic mechanism between alzheimer\u2019s disease and diabetes","volume":"9","author":"Stanciu","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.008_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimer's Dis"},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.008_bib48","doi-asserted-by":"crossref","first-page":"a006148","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ibneur.2025.01.008_bib49","series-title":"Greenfield's Neuropathology-Two Volume Set","first-page":"25","article-title":"General pathology of the central nervous system","author":"Vinters","year":"2018"},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.008_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ph13110379","article-title":"Perspective of SGLT2 inhibition in treatment of conditions connected to neuronal loss: focus on Alzheimer\u2019s disease and ischemia-related brain injury","volume":"13","author":"Wici\u0144ski","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.008_bib51","first-page":"6372059","article-title":"Scopolamine-induced memory impairment in mice: neuroprotective effects of carissa edulis (Forssk.) Valh (Apocynaceae) aqueous extract","volume":"2020","author":"Yadang","year":"2020","journal-title":"Int. J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.ibneur.2025.01.008_bib52","article-title":"Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis","author":"Youn","year":"2024","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.008_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/rej.2012.1389","article-title":"Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats","volume":"16","author":"Zeng","year":"2013","journal-title":"Rejuvenation Res."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:32:55Z","timestamp":1784359975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242125000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"alternative-id":["S2667242125000089"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.01.008","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}